Collagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survival

被引：37

作者：

Barton, C. A. ^{[1
]}

Gloss, B. S. ^{[1
]}

Qu, W. ^{[1
]}

Statham, A. L. ^{[1
]}

Hacker, N. F. ^{[1
,2
,3
]}

Sutherland, R. L. ^{[1
,3
]}

Clark, S. J. ^{[1
,3
]}

O'Brien, P. M. ^{[1
,3
]}

机构：

[1] St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia

[2] Royal Hosp Women, Gynaecol Canc Ctr, Randwick, NSW 2031, Australia

[3] Univ NSW, Fac Med, Sydney, NSW 2031, Australia

来源：

BRITISH JOURNAL OF CANCER | 2010年 / 102卷 / 01期

基金：

英国医学研究理事会;

关键词：

ovarian cancer; CCBE1; tumour suppressor; ASPARAGINYL-BETA-HYDROXYLASE; COMPARATIVE GENOMIC HYBRIDIZATION; GROWTH-FACTOR; GENE-EXPRESSION; HEPATOCELLULAR-CARCINOMA; VITELLOGENIN RECEPTOR; DNA METHYLATION; OVEREXPRESSION; CHOLANGIOCARCINOMA; ASSOCIATION;

D O I：

10.1038/sj.bjc.6605429

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

BACKGROUND: Collagen and calcium-binding EGF domains 1 (CCBE1) is an uncharacterised gene that has down-regulated expression in breast cancer. As CCBE1 maps to 18q21.32, a region frequently exhibiting loss of heterozygosity in ovarian cancer, the aim of this study was to determine the expression and function of CCBE1 in ovarian cancer. METHODS: Expression and methylation patterns of CCBE1 were determined in ovarian cancer cell lines and primary tumours. CCBE1 contains collagen repeats and an aspartic acid/asparagine hydroxylation/EGF-like domain, suggesting a function in extracellular matrix remodelling and migration, which was determined using small-interfering RNA (siRNA)-mediated knockdown and over-expression of CCBE1 in cell lines. RESULTS: CCBE1 is expressed in normal ovary, but is reduced in ovarian cancer cell lines and primary carcinomas. Pharmacological demethylation/deacetylation in ovarian cancer cell lines re-induced CCBE1 expression, indicating that epigenetic mechanisms contribute to its silencing in cancer. CCBE1 promoter hypermethylation was detected in 6/11 (55%) ovarian cancer cell lines and 38/81 (41%) ovarian carcinomas. siRNA-mediated knockdown of CCBE1 in ovarian cancer cell lines enhanced their migration; conversely, re-expression of CCBE1 reduced migration and survival. Hence, loss of CCBE1 expression may promote ovarian carcinogenesis by enhancing migration and cell survival. CONCLUSIONS: These data suggest that CCBE1 is a new candidate tumour suppressor in ovarian cancer. British Journal of Cancer (2010) 102, 87-96. doi:10.1038/sj.bjc.6605429 www.bjcancer.com Published online 24 November 2009 (C) 2010 Cancer Research UK

引用

页码：87 / 96

页数：10

共 39 条

[21]

The fundamental role of epigenetic events in cancer [J].

Jones, PA ;

Baylin, SB .

NATURE REVIEWS GENETICS, 2002, 3 (06) :415-428

[22]

Analysis of ovarian cancer cell lines using array-based comparative genomic hybridization [J].

Lambros, MBK ;

Fiegler, H ;

Jones, A ;

Gorman, P ;

Roylance, RR ;

Carter, NP ;

Tomlinson, IPM .

JOURNAL OF PATHOLOGY, 2005, 205 (01) :29-40

[23]

Allelic analysis of serous ovarian carcinoma reveals two putative tumor suppressor loci at 18q22-q23 distal to SMAD4, SMAD2, and DCC [J].

Lassus, H ;

Salovaara, R ;

Aaltonen, LA ;

Butzow, R .

AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (01) :35-42

[24]

Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma [J].

Lavaissiere, L ;

Jia, S ;

Nishiyama, M ;

delaMonte, S ;

Stern, AM ;

Wands, JR ;

Friedman, PA .

JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (06) :1313-1323

[25]

SINGLE AMINO-ACID SUBSTITUTIONS IN EGF-LIKE ELEMENTS OF NOTCH AND DELTA-MODIFY DROSOPHILA DEVELOPMENT AND AFFECT CELL-ADHESION INVITRO [J].

LIEBER, T ;

WESLEY, CS ;

ALCAMO, E ;

HASSEL, B ;

KRANE, JF ;

CAMPOSORTEGA, JA ;

YOUNG, MW .

NEURON, 1992, 9 (05) :847-859

[26]

Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis [J].

Lu, KH ;

Patterson, AP ;

Wang, L ;

Marquez, RT ;

Atkinson, EN ;

Baggerly, KA ;

Ramoth, LR ;

Rosen, DG ;

Liu, JS ;

Hellstrom, I ;

Smith, D ;

Hartmann, L ;

Fishman, D ;

Berchuck, A ;

Schmandt, R ;

Whitaker, R ;

Gershenson, DM ;

Mills, GB ;

Bast, RC .

CLINICAL CANCER RESEARCH, 2004, 10 (10) :3291-3300

[27]

Antisense oligodeoxynucleotides directed against aspartyl (asparaginyl) β-hydroxylase suppress migration of cholangiocarcinoma cells [J].

Maeda, T ;

Sepe, P ;

Lahousse, S ;

Tamaki, S ;

Enjoji, M ;

Wands, JR ;

de la Monte, SM .

JOURNAL OF HEPATOLOGY, 2003, 38 (05) :615-622

[28]

INVERTEBRATE ASPARTYL ASPARAGINYL BETA-HYDROXYLASE - POTENTIAL MODIFICATION OF ENDOGENOUS EPIDERMAL GROWTH FACTOR-LIKE MODULES [J].

MONKOVIC, DD ;

VANDUSEN, WJ ;

PETROSKI, CJ ;

GARSKY, VM ;

SARDANA, MK ;

ZAVODSZKY, P ;

STERN, AM ;

FRIEDMAN, PA .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 189 (01) :233-241

[29]

Cyclin D1 overexpression induces progestin resistance in T-47D breast cancer cells despite p27KP1 association with cyclin E-Cdk2 [J].

Musgrove, EA ;

Hunter, LJK ;

Lee, CSL ;

Swarbrick, A ;

Hui, R ;

Sutherland, RL .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (50) :47675-47683

[30]

Headloop suppression PCR and its application to selective amplification of methylated DNA sequences [J].

Rand, KN ;

Ho, T ;

Qu, WJ ;

Mitchell, SM ;

White, R ;

Clark, SJ ;

Molloy, PL .

NUCLEIC ACIDS RESEARCH, 2005, 33 (14) :1-11

← 1 2 3 4 →